CL-242817 is an orally active angiotensin-converting enzyme (ACE) inhibitor that lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II; it also ameliorates monocrotaline-induced lung injury and can be used in the research of pulmonary fibrosis and hypertension-related diseases.